FdaApplication
NDA 208255
Identifiers
- fda_app_no: NDA208255
Properties
| Property | Value |
|---|---|
| applicant_name | MYLAN PHARMACEUTICALS INC |
| application_type | NDA |
| approval_date | 2018-02-05 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| SYMFI LO | EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE | 400MG;300MG;300MG | TABLET;ORAL |
1 product